Insiders Roche Holding AG

Equities

ROG

CH0012032048

Pharmaceuticals

Market Closed - Swiss Exchange Other stock markets 12:30:11 2026-03-13 pm EDT			5-day change	1st Jan Change
320.70 ^CHF	+0.79%		-6.01%	-2.29%

Mar. 12	ROCHE HOLDINGS AG : Deutsche Bank reaffirms its Neutral rating	ZD
Mar. 12	ROCHE HOLDINGS AG : Receives a Buy rating from Barclays	ZD

Insiders

Mar. 10	MBX Biosciences, Inc. Appoints Karen Basbaum As Chief Business Officer	CI
Mar. 10	Roche Holding Ag Elects Lubomira Rochet to the Board of Directors	CI
Mar. 03	Roche Holding AG Appoints Olalla Grau as Its New CEO in Sweden, Effective 1 April 2026	CI
Feb. 26	Keros Therapeutics, Inc. Announces Board Changes, Effective March 9, 2026	CI
Feb. 26	CEO of World Economic Forum quits after Epstein ties come to light	RE
Feb. 26	CEO of World Economic Forum quits after Epstein ties come to light	RE
Feb. 24	Adocia SA Announces Board Changes	CI
Feb. 23	Zura Bio Limited Announces Board Changes, Effective February 21, 2026	CI
Feb. 17	Roche appoints Mark Dawson as new head of Roche pharma research and early development	RE
Feb. 17	Roche Announces the Appointment of Mark Dawson as New Head of Roche Pharma Research and Early Development and Member of the Enlarged Corporate Executive Committee, Effective 1 May 2026	CI
Feb. 09	Avacta appoints new chief scientific officer, plans clinical trials	AN
Feb. 09	Avacta Therapeutics Announces Executive Changes	CI
Feb. 04	Stadler Rail says Christoph Franz and Wojciech Kostrzewa will not be standing for re-election to board	RE
Feb. 04	Stadler Rail AG Announces Board Resignations	CI
Feb. 02	STAAR Surgical Company Announces Interim Co-CEO Appointments, Effective February 1, 2026	CI
Jan. 21	LB Pharmaceuticals Inc Appoints Minako Pazdera as General Counsel	CI
Jan. 21	Swiss stocks - Factors to watch on January 21	RE
Jan. 13	Roche Pharma CEO on Company's Obesity Assets	MT
Jan. 07	THX Pharma Announces Appointment of Julien Veys as Deputy Chief Executive Officer	CI
Dec. 11	Enliven Therapeutics, Inc. Announces Chief Executive Officer Changes, Effective December 11, 2025	CI
Nov. 30	Archer Materials Limited Announces Board Changes, Effective December 1, 2025	CI
Nov. 10	Nokia Recruits Roche Executive as Chief People Officer	MT
Nov. 04	Taysha Gene Therapies, Inc. Appoints David McNinch as Chief Commercial Officer in September 2025	CI
25-10-23	BASF Announces Departure of Dr. Nina Schwab-Hautzinger as Head of Corporate Communications & Government Relations, Effective January 31, 2026	CI
25-10-23	Roche Announces Appointment of Nina Schwab-Hautzinger as Head of Group Communications and Member of the Enlarged Corporate Executive Committee, Effective 1 February 2026	CI